PDF(Pubmed)
Abstract：
Public stigma surrounds individuals who use medication for their recovery from a substance use disorder. However, we know little about subgroups of individuals with varying levels of perceived stigma and how these levels may be associated with physical and mental health-related quality of life (HRQOL) and social support.
We used latent class analysis to define subgroups of people aged 50-72 years of age (N = 104) who were enrolled in eight medication for opioid use disorder (MOUD) programs to explore subgroupings and correlates of group membership.
We found evidence for three distinct classes of individuals and named the classes 1) the high stigma class, 2) the embarrassed class, and 3) the low stigma class. We found that people in the high-stigma class reported more rejection, more abstinence-based support group involvement, and reduced mental HRQOL.
Results suggest reducing stigma among people on MOUD may help to boost mental HRQOL and improve social support receipt. The results are consistent with iatrogenic effects of AA/NA support groups such that these treatment modalities may increase stigma due to their focus on abstinence-only treatment for substance use disorders.
We used latent class analysis to define subgroups of people aged 50-72 years of age (N = 104) who were enrolled in eight medication for opioid use disorder (MOUD) programs to explore subgroupings and correlates of group membership.
We found evidence for three distinct classes of individuals and named the classes 1) the high stigma class, 2) the embarrassed class, and 3) the low stigma class. We found that people in the high-stigma class reported more rejection, more abstinence-based support group involvement, and reduced mental HRQOL.
Results suggest reducing stigma among people on MOUD may help to boost mental HRQOL and improve social support receipt. The results are consistent with iatrogenic effects of AA/NA support groups such that these treatment modalities may increase stigma due to their focus on abstinence-only treatment for substance use disorders.
摘要：
背景：公共污名围绕着使用药物从物质使用障碍中恢复的个体。然而,我们对具有不同程度的病耻感的个体亚组以及这些水平如何与身心健康相关的生活质量(HRQOL)和社会支持相关知之甚少.
方法：我们使用潜在类别分析来定义年龄在50-72岁（N=104）的人群亚组，这些人群参加了八种阿片类药物使用障碍（MOUD）计划，以探索亚组和组成员的相关性。
结果：我们发现了三个不同类别的个体的证据，并将其命名为类别1）高污名类别，2）尴尬的班级，3)低污名等级。我们发现高污名阶层的人报告了更多的拒绝，更多基于禁欲的支持小组参与，降低心理HRQOL。
结论：结果表明，减少MOUD人群的污名可能有助于提高心理HRQOL并改善社会支持接收。结果与AA/NA支持组的医源性作用一致，因此这些治疗方式可能会增加污名，因为它们专注于禁欲治疗物质使用障碍。
方法：我们使用潜在类别分析来定义年龄在50-72岁（N=104）的人群亚组，这些人群参加了八种阿片类药物使用障碍（MOUD）计划，以探索亚组和组成员的相关性。
结果：我们发现了三个不同类别的个体的证据，并将其命名为类别1）高污名类别，2）尴尬的班级，3)低污名等级。我们发现高污名阶层的人报告了更多的拒绝，更多基于禁欲的支持小组参与，降低心理HRQOL。
结论：结果表明，减少MOUD人群的污名可能有助于提高心理HRQOL并改善社会支持接收。结果与AA/NA支持组的医源性作用一致，因此这些治疗方式可能会增加污名，因为它们专注于禁欲治疗物质使用障碍。
